Tag: Insulin pumps
Medically Modern builds scale through practice partnerships, payer access
September 25, 2026HME News Staff
NEW YORK – Medically Modern is in growth mode with a new model that uses its insurance expertise and customized technology to help physicians better manage their diabetes patients, says founder and CEO Corey Deutsch.
Medically Modern recently announced a new partnership with an independent, multi-location endocrinology practice in Northern Virginia to manage prior authorization and fulfillment for its continuous glucose monitor (CGM) and insulin pump referrals.
‘We speak fluent...
In brief: MA fraud, Abbott settlement, MiniMed separation, SoClean commercial
September 16, 2026HME News Staff
WASHINGTON – The Office of Inspector General (OIG) says it has identified gaps in the screening process for fraudulent DMEPOS suppliers in Medicare Advantage.
The agency issued a report on Sept. 9 saying Medicare Advantage organizations (MAOs) conduct some screening checks on in-network suppliers but fewer checks of out-of-network suppliers. It also says:
The Centers for Medicare & Medicaid Services (CMS) does not screen all DEMPOS suppliers before they bill Medicare Advantage because...
MiniMed Flex gains Medicare coverage
July 22, 2026HME News Staff
NORTHRIDGE, Calif. – Medicare and Medicare Advantage beneficiaries now have access to the MiniMed Flex insulin pump system and its latest sensor portfolio, MiniMed has announced. "Managing diabetes is relentless and no one should have to do it without the best tools available," said Que Dallara, CEO of MiniMed. "Ensuring Medicare access to MiniMed Flex is about making sure more people can benefit from technology that fits into daily life and takes some of the burden off their...
Medtronic rolls out MiniMed 780G insulin pump system with Instinct sensor in US
December 5, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems. The Instinct sensor is based on Abbott's most advanced continuous glucose monitoring (CGM) technology, featuring a small discreet sensor with a wear time of up to 15 days. When paired with the MiniMed 780G system,...
Tandem’s t:slim integrates with FreeStyle Libre 3 Plus
October 29, 2025HME News Staff
SAN DIEGO – Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor integration in the United States. This is the first step in a global commercial rollout that expands choice and personalization for people living with diabetes worldwide, the company says. “With this integration, we expand...
Medtronic receives FDA approval for iAGC
September 3, 2025HME News Staff
GALWAY, Ireland – Medtronic has received clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with Abbott’s Instinct sensor for Type 1 diabetes. The company has also received approval of the MiniMed 780G system for use in adults 18+ with insulin-requiring Type 2 diabetes. "These milestones mark an important next step in our work to bring the proven performance and outcomes of our MiniMed 780G automated insulin delivery...
Insulet reports ‘robust’ quarter
August 7, 2025HME News Staff
ACTON, Mass. - Insulet reported revenue of $649.1 million for the second quarter of 2025, up 32.9% compared to the same period last year.
Total Omnipod revenue was $639 million, up 33%. Of that, U.S. Omnipod revenue was $453.2 million, up 28.7%, and international Omnipod revenue was $185.8 million, up 45%. Adjusted EBITDA was $157.5 million.
“We delivered robust second quarter results, reflecting our team’s strong performance and the compelling impact and appeal...
Medtronic to split off diabetes biz
May 21, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced it intends to separate its diabetes business, which represented 8% of revenue and 4% of segment operating profit in fiscal year 2025, into a new standalone company.
The new diabetes company will be a leading, scaled direct-to-consumer diabetes business uniquely positioned to commercialize a complete intensive insulin management ecosystem, Medtronic says.
"This marks a significant milestone in driving both Medtronic and the diabetes...
AdaptHealth works on diabetes, as sleep & oxygen make gains
March 1, 2024Theresa Flaherty
PLYMOUTH MEETING, Pa. - Diabetes revenue for the fourth quarter of 2023 was down 3.8% against the prior year, driven in part by compression on insulin pumps, but AdaptHealth execs say they plan a big push to boost that part of the business in 2024.
Pump revenue in 2022 was about $160 million, and the company expected revenue of about $120 million in 2023.
“We came right in line with that expectation,” said Jason Clemens, CFO, during a recent call to discuss the company’s...
Tandem study shows great improvement for high A1c
April 18, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...